Sintx Technologies, Inc.
Close on Oct 19, 2026
- Market cap
- $8.24M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Nov 12, 2026, before market open (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 11, 2026 | After market close | – | – | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 13, 2025 | Before market open | $200.00K | $-1.19 | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 15, 2025 | Before market open | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Jan 23, 2024 | Before market open | $902.00K | – | – |
| Q4 FY2022 Ended Dec 31, 2022 | Jan 25, 2023 | After market close | – | – | – |
| Q3 FY2016 Ended Sep 30, 2016 | Nov 10, 2016 | After market close | – | – | – |
| Q2 FY2016 Ended Jun 30, 2016 | Aug 11, 2016 | After market close | – | – | – |
| Q1 FY2016 Ended Mar 31, 2016 | May 12, 2016 | After market close | – | – | – |
| Q4 FY2015 Ended Dec 31, 2015 | Mar 17, 2016 | After market close | – | – | – |
| Q2 FY2015 Ended Jun 30, 2015 | Jul 27, 2015 | After market close | – | – | – |
| Q1 FY2015 Ended Mar 31, 2015 | May 7, 2015 | After market close | – | – | – |
Company guidance
Outlook given with results on Aug 11, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| total revenue | third quarter of 2026 | $900.00K to $1.10M | New |
| total revenue | fourth quarter of 2026 | $1.00M to $1.30M | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Sintx Technologies filed with the SEC
Announces Preliminary $2.2 Million in Q3 Revenue, Exceeding High-End Guidance
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Technologies Regains Compliance with Nasdaq Stockholders’ Equity Requirement
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
SINTX Technologies Engages Veteran MedTech Executive
Regulation FD disclosure · EX-99.1 to Form 8-K
Technologies Announces Raise of Approximately $5.0 Million of Capital, Including a $4.5 Million Private Placement Priced At-the-Market
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
SINTX Technologies Signs Supply Agreement with EVONIK
Regulation FD disclosure · EX-99.1 to Form 8-K
Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Technologies Submits FDA 510(k) for Silicon Nitride Foot & Ankle Medical Devices
Regulation FD disclosure · EX-99.1 to Form 8-K
Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market
Regulation FD disclosure · EX-99.1 to Form 8-K
Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Technologies Announces $5 Million Private
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer
Executive or director change · Other events · EX-99.1 to Form 8-K
Technologies Announces Stock Repurchase Program
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Technologies Announces Appointment of Eric K. Olson as Chief Executive Officer
Executive or director change · Other events · EX-99.1 to Form 8-K
Technologies Regains Compliance with Nasdaq Bid Price Requirement
Other events · EX-99.1 to Form 8-K
TECHNOLOGIES Announces Reverse Stock Split Effective May 28, 2024
Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
Technologies Announces Proposed Public Offering of Common Stock
Material agreement · Other events · EX-99.1 to Form 8-K
Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock
Material agreement · Other events · EX-99.2 to Form 8-K
Technologies Announces Proposed Public Offering of Common Stock
Material agreement · Other events · EX-99.1 to Form 8-K
Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock
Material agreement · Other events · EX-99.2 to Form 8-K
TECHNOLOGIES ANNOUNCES PRICING OF $4.0 MILLION PUBLIC OFFERING
Material agreement · Other events · EX-99.1 to Form 8-K
SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4
Results of operations · EX-99.1 to Form 8-K
TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO
Other events · EX-99.1 to Form 8-K
TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS
Other events · EX-99.1 to Form 8-K
Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants
Other events · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Material agreement · Other events · EX-99.1 to Form 8-K
Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update
Results of operations · EX-99.1 to Form 8-K
TECHNOLOGIES Announces Reverse Stock Split Effective DECEMBER 20, 2022
Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
TECHNOLOGIES Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
Regulation FD disclosure · EX-99.1 to Form 8-K
Technologies Acquires Technology Assessment and Transfer, Inc.
Material agreement · Acquisition or disposition completed · Regulation FD disclosure · EX-99.1 to Form 8-K
Technologies Ends Patent License Agreement With O2TODAY
Agreement terminated · Regulation FD disclosure · EX-99.1 to Form 8-K
Technologies Shares Q3 2021 Revenue Update
Shareholder vote results · Other events · EX-99.1 to Form 8-K